Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EY Capital Advisors is the US broker-dealer and investment banking affiliate of EY, focused on middle-market mergers and acquisitions, debt capital markets, and equity capital markets advisory. The business operates as part of EY’s broader strategy and transactions organization and serves clients across multiple industries, including healthcare, technology, industrials, energy, automotive, and consumer sectors. It is not a biotechnology, pharmaceutical, or healthcare operating company; rather, it advises companies and investors on financing and transaction execution. For biotech and healthcare analysts, EY Capital Advisors is best understood as a sector-covering financial advisor that may work on healthcare and life sciences deals rather than a therapeutic developer or healthcare services provider.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EY Capital Advisors.